330 related articles for article (PubMed ID: 7788964)
1. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
2. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration.
Tanaka K; Tanaka M; Onodera O; Igarashi S; Miyatake T; Tsuji S
J Neurol Sci; 1994 Dec; 127(2):153-8. PubMed ID: 7707074
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
5. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
[TBL] [Abstract][Full Text] [Related]
8. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
Matsushita H; Kodama S; Aoki Y; Tanaka K; Tanaka K; Saito N
Gynecol Obstet Invest; 1998; 45(2):140-3. PubMed ID: 9517809
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
12. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.
Graus F; Illa I; Agusti M; Ribalta T; Cruz-Sanchez F; Juarez C
J Neurol Sci; 1991 Nov; 106(1):82-7. PubMed ID: 1779243
[TBL] [Abstract][Full Text] [Related]
13. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Nakajima T; Yamazaki M; Miyatake T; Tsuji S
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
[No Abstract] [Full Text] [Related]
14. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
17. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
18. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration: successful early detection and treatment of cancer through characterization of the anti-Purkinje cell antibody.
Tanaka K; Igarashi S; Yamazaki M; Nakajima T; Miyatake T; Sakai K
Intern Med; 1992 Dec; 31(12):1339-42. PubMed ID: 1300168
[TBL] [Abstract][Full Text] [Related]
20. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
Lennon VA; Kryzer TJ
Neurology; 1998 Jul; 51(1):327-9. PubMed ID: 9674845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
